相关实验视频
Updated: May 29, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.3K
在患有原发性阿尔多斯特主义的患者中,上腺切除术后功能发生变化
Yumi Tomiie1, Yatsuka Hibi1, Rie Nobe1,2
1Department of Endocrine Surgery, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Fujita medical journal
|February 3, 2025
概括
在为原发性阿尔多斯特隆症 (PA) 进行上腺切除术后,估计的淋巴球过率 (eGFR) 的下降是常见的. 这种功能障碍是通过手术揭露的,高血压和低预测下降.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
背景情况:
- 原发性阿尔多斯子主义 (PA) 可以掩盖功能障碍.
- 对PA进行上腺切除术可能会揭示潜在的脏问题.
- 估计膜过率 (eGFR) 变化需要进行上腺切除术后的调查.
研究的目的:
- 评估PA患者上腺切除术揭露的功能障碍.
- 通过使用"eGFR中的某种下降"指南,研究上腺切除术后eGFR的变化.
- 为了确定EGFR下降后上腺切除术后的预测因素.
主要方法:
- 对54名接受单边上腺切除术的PA患者进行了回顾性研究.
- 根据手术前和手术后的eGFR将患者分为GFR类别.
- 多变量回归分析以确定显著的EGFR下降 (≥25%的下降) 的预测因素.
主要成果:
- 35.2%的患者在上腺切除术后经历了显著的EGFR下降.
- 预测因素包括更长的高血压持续时间和较低的手术前血清.
- 术前血清水平为3.7 mmol/L是一个显著的切断值.
结论:
- 在PA患者中,上腺切除术后的eGFR下降是一个公认的现象.
- 高血压持续时间和手术前的水平是关键预测因素.
- 发现有助于外科医生为患者提供咨询,了解潜在的GFR类别变化.
相关概念视频
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics
441
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
441
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
Regulation of Sodium and Potassium
382
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
382

